Penicillin G Sodium Prices

Penicillin G Sodium Price Trend, Index and Forecast

Track the latest insights on penicillin g sodium price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Penicillin G Sodium Prices Outlook Q2 2026

• USA: USD 51,453/MT
• Germany: USD 52,060/MT
• France: USD 51,784/MT
• China: USD 50,912/MT
• Canada: USD 53,259/MT

Penicillin G Sodium Price Chart

Get real-time access to monthly/quarterly/yearly prices Request Sample

During the second quarter of 2026, the penicillin G sodium prices in the USA reached 51,453 USD/MT in June. The market moved higher as pharmaceutical buyers faced firmer procurement costs for antibiotic active pharmaceutical ingredients. Manufacturing expenses were influenced by fermentation requirements, precursor availability, energy consumption, and quality control requirements. Greater attention to reliable supply encouraged buyers to secure material from established manufacturers, supporting firmer transaction levels.

During the second quarter of 2026, the penicillin G sodium prices in Germany reached 52,060 USD/MT in June. European prices strengthened as pharmaceutical manufacturers managed higher sourcing costs and continued to prioritize dependable supplies of established antibiotic APIs. Penicillin production requires specialized fermentation, purification, quality assurance, and controlled processing, making production costs sensitive to changes in utilities, precursor inputs, and plant operating conditions.

During the second quarter of 2026, the penicillin G sodium prices in France reached 51,784 USD/MT in June. French market conditions reflected firmer purchasing interest from pharmaceutical manufacturers and distributors seeking consistent supplies of antibiotic ingredients. The market remained influenced by the specialized nature of penicillin production, where fermentation performance, precursor quality, purification efficiency, and sterile processing requirements can affect production economics.

During the second quarter of 2026, the penicillin G sodium prices in China reached 50,912 USD/MT in June. China remained an important production center for penicillin related APIs, with market pricing supported by stronger procurement activity and manufacturing cost considerations. Penicillin G is produced biologically through controlled fermentation followed by recovery and purification, making output sensitive to culture performance, precursor availability, utilities, and plant operating conditions.

During the second quarter of 2026, the penicillin G sodium prices in Canada reached 53,259 USD/MT in June. Canadian prices recorded the strongest supplied quarterly increase, reflecting firmer pharmaceutical sourcing costs and continued dependence on qualified API suppliers. Penicillin G sodium is used in sterile injectable antibiotic products, making consistent quality, controlled processing, and reliable supplier qualification important for procurement decisions.

Penicillin G Sodium Prices Outlook Q1 2026

• USA: USD 48,486/MT
• Germany: USD 48,663/MT
• France: USD 48,619/MT
• China: USD 47,639/MT
• Canada: USD 49,817/MT

During the first quarter of 2026, the penicillin G sodium prices in the USA reached 48,486 USD/MT in March. The market experienced a firm upward trend driven by steady pharmaceutical demand and improved procurement activity from healthcare manufacturers. Supply chain conditions remained relatively stable, although intermittent logistical constraints influenced distribution efficiency. Feedstock availability showed moderate consistency, supporting production continuity.

During the first quarter of 2026, the penicillin G sodium prices in Germany reached 48,663 USD/MT in March. The market reflected a positive price movement supported by consistent demand from the pharmaceutical industries and controlled supply conditions. Manufacturing output remained steady, though energy related production costs exerted upward pressure on overall pricing. Imports played a supportive role in maintaining supply levels, while inventory management remained cautious.

During the first quarter of 2026, the penicillin G sodium prices in France reached 48,619 USD/MT in March. The market exhibited a moderate upward trend influenced by steady pharmaceutical sector demand and stable production activity. Supply conditions remained adequate, although logistical inefficiencies in certain regions impacted timely deliveries. Production costs were affected by energy pricing and compliance requirements, which contributed to pricing adjustments.

During the first quarter of 2026, the penicillin G sodium prices in China reached 47,639 USD/MT in March. The market showed an upward trajectory driven by stable production levels and consistent domestic demand. Export activity remained moderate, supporting market balance without causing supply strain. Feedstock availability was stable, enabling uninterrupted manufacturing operations. However, regulatory monitoring and environmental compliance added to production costs, contributing to the price rise.

During the first quarter of 2026, the penicillin G sodium prices in Canada reached 49,817 USD/MT in March. The market experienced a gradual increase in prices supported by stable healthcare sector demand and consistent import flows. Domestic production remained limited, making the market reliant on imports, which influenced pricing trends. Logistics and transportation costs contributed to higher procurement expenses. Supply chain stability ensured adequate availability, while inventory levels were carefully managed.

Penicillin G Sodium Prices Outlook Q4 2025

• USA: USD 48,073/MT
• Germany: USD 48,072/MT
• France: USD 47,934/MT
• China: USD 47,125/MT
• Canada: USD 49,270/MT

During the fourth quarter of 2025, the penicillin G sodium prices in the USA reached 48,073 USD/MT in December. The market reflected a marginal correction compared to the previous quarter, largely influenced by balanced domestic inventories and steady pharmaceutical demand. Improved fermentation yields and stable availability of key raw materials eased production cost pressures. Additionally, moderate export inquiries and stable freight conditions contributed to a softer pricing environment. Procurement activities remained cautious as buyers relied on existing contracts and sufficient stock levels.

During the fourth quarter of 2025, the penicillin G sodium prices in Germany reached 48,072 USD/MT in December. The market experienced a mild decline driven by improved supply availability across the European pharmaceutical manufacturing sector. Stable energy markets and smoother logistics operations reduced overall cost burdens for producers. Demand from downstream antibiotic formulators remained consistent but lacked significant expansion, resulting in limited spot market activity.

During the fourth quarter of 2025, the penicillin G sodium prices in France reached 47,934 USD/MT in December. The French market recorded a slight downturn due to stable domestic production levels and sufficient inventory coverage among pharmaceutical manufacturers. Demand from hospitals and healthcare distributors remained steady but did not demonstrate accelerated purchasing. Improved upstream raw material supply and controlled energy expenses supported production continuity.

During the fourth quarter of 2025, the penicillin G sodium prices in China reached 47,125 USD/MT in December. The market saw a moderate softening trend influenced by consistent fermentation output and adequate availability of intermediates. Export demand remained stable but slightly moderated compared to earlier momentum. Domestic pharmaceutical production operated at steady rates, limiting supply constraints. Freight rates and port operations remained efficient, supporting uninterrupted exports.

During the fourth quarter of 2025, the penicillin G sodium prices in Canada reached 49,270 USD/MT in December. The market displayed a slight decrease driven by sufficient import availability and steady domestic pharmaceutical demand. Supply chains functioned smoothly with stable cross-border trade flows from the United States and other regions. Procurement remained disciplined as buyers maintained adequate inventories. Energy and transportation costs showed stability, limiting production volatility.

Penicillin G Sodium Prices Outlook Q3 2025

• USA: USD 48,398/MT
• Germany: USD 48,494/MT
• France: USD 48,243/MT
• China: USD 47,486/MT
• Canada: USD 49,433/MT

During the third quarter of 2025, the penicillin G sodium prices in the USA reached 48,398 USD/MT in September. The market experienced upward momentum supported by firm pharmaceutical demand and active procurement cycles. Tight supply conditions earlier in the quarter encouraged buyers to secure volumes through forward contracts. Production costs were influenced by stable yet firm raw material availability. Export activity remained healthy, adding to domestic supply pressure. Transportation expenses and compliance-related expenditures also contributed to elevated offers.

During the third quarter of 2025, the penicillin G sodium prices in Germany reached 48,494 USD/MT in September. The market recorded growth driven by resilient antibiotic demand and steady restocking by pharmaceutical manufacturers. Limited spot availability at certain points encouraged higher contract negotiations. Energy and compliance costs remained firm, supporting upward pricing revisions. Import competition existed but did not significantly offset domestic demand strength.

During the third quarter of 2025, the penicillin G sodium prices in France reached 48,243 USD/MT in September. France observed a notable increase influenced by consistent hospital demand and replenishment activities across distribution networks. Domestic production maintained stability, but export commitments limited local spot availability. Raw material procurement remained structured, with producers reflecting firm costs in quotations. Cross-border European trade supported supply continuity while sustaining competitive pricing.

During the third quarter of 2025, the penicillin G sodium prices in China reached 47,486 USD/MT in September. The market witnessed upward movement driven by strong export inquiries and steady fermentation activity. Domestic demand from formulation manufacturers remained firm, supporting higher transaction levels. Raw material and operational expenses were stable yet influential in price discussions. Export competitiveness and active overseas contracts supported producers’ bargaining positions.

During the third quarter of 2025, the penicillin G sodium prices in Canada reached 49,433 USD/MT in September. The market recorded growth driven by steady healthcare demand and firm import prices. Cross-border trade with the United States supported supply continuity but at elevated contract values. Buyers engaged in forward purchasing to secure volumes amid active pharmaceutical production. Transportation and compliance costs influenced supplier quotations. Inventory restocking contributed to positive price sentiment.

Penicillin G Sodium Prices Outlook Q2 2025

• USA: USD 47,500/MT
• Germany: USD 47,900/MT
• France: USD 47,200/MT
• China: USD 46,450/MT

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing penicillin G sodium prices.

Europe Penicillin G Sodium Price Trend

Q2 2026:

The penicillin G sodium price index moved upward as pharmaceutical manufacturers faced firmer sourcing costs and maintained purchasing from qualified API suppliers. European procurement remained sensitive to pharmaceutical availability requirements, supplier qualification, manufacturing compliance, and quality assurance expenses. Penicillin products require dedicated controls because of the potential for cross contamination, increasing the operational burden associated with production and handling. Fermentation conditions, precursor availability, purification costs, utilities, and facility utilization also influenced supplier offers. Buyers continued replenishing inventories while prioritizing dependable delivery and consistent quality.

Q1 2026:

The penicillin G sodium price index in Europe showed a steady upward trend. The region experienced balanced supply and demand conditions supported by consistent pharmaceutical manufacturing activity. Production costs increased due to energy and regulatory compliance factors, contributing to price strengthening. Import flows remained stable, while inventory levels were managed efficiently. Demand from healthcare sectors remained firm, sustaining market momentum. Overall, the market maintained a positive trajectory with gradual price increases driven by cost pressures and stable consumption.

Q4 2025:

The penicillin G sodium price index in Europe reflected a mild decline during the fourth quarter of 2025. Stable pharmaceutical manufacturing demand and improved supply availability supported balanced conditions. Energy markets remained steady, easing operational cost pressures. Intra-regional trade flows enhanced competitive pricing. Inventory levels across major distribution hubs were adequate, limiting aggressive procurement. Regulatory stability further maintained smooth production, resulting in modest downward adjustments.

Q3 2025:

The penicillin G sodium price index in Europe increased during the third quarter of 2025. Firm healthcare demand across major economies supported consistent offtake from pharmaceutical manufacturers, particularly for injectable antibiotic formulations. Active restocking by distributors and hospital networks further strengthened purchasing activity following earlier inventory drawdowns. Production costs remained stable yet firm, influenced by steady energy expenses and controlled raw material availability, which reinforced supplier confidence in maintaining elevated quotations.

This analysis can be extended to include detailed penicillin G sodium price information for a comprehensive list of countries.

North America Penicillin G Sodium Price Trend

Q2 2026:

The penicillin G sodium price index increased during Q2 2026 as buyers encountered firmer API sourcing costs and maintained procurement despite higher offers. The regional market remained supported by demand for injectable antibiotic manufacturing, where penicillin G sodium is used as a sterile active ingredient. Supplier qualification, quality testing, controlled storage, and manufacturing segregation remained important cost considerations. Penicillin facilities require strong contamination controls, adding operating and compliance expenses that can be reflected in supplier pricing. North American buyers also remained exposed to international API supply conditions, transportation costs, and availability from qualified producers.

Q1 2026:

The penicillin G sodium price index in North America recorded a moderate increase. The region benefited from stable demand across pharmaceutical industries and consistent supply chain operations. Import dependency influenced pricing, especially in markets with limited domestic production. Logistics and compliance costs contributed to upward price pressure. Inventory management remained cautious, preventing oversupply conditions. The market sentiment remained firm, supported by steady procurement activity and stable production levels.

Q4 2025:

The penicillin G sodium price index in North America experienced a slight correction. Sufficient domestic production, supported by stable fermentation operations and uninterrupted raw material availability, maintained comfortable supply levels across the region. Consistent import inflows further reinforced market balance, preventing any structural tightness. Demand from hospitals, pharmaceutical formulators, and government procurement programs remained steady, aligned with routine healthcare consumption patterns.

Q3 2025:

The penicillin G sodium price index in North America rose. Pharmaceutical manufacturers operated at consistent output levels to meet ongoing healthcare demand, particularly from hospital procurement programs and contract manufacturing organizations. Proactive purchasing strategies by buyers seeking supply security encouraged firmer contract negotiations. Import prices from overseas suppliers remained firm, limiting the scope for domestic price concessions and strengthening overall market sentiment. Raw material sourcing and operational expenses were stable but sufficiently elevated to justify higher supplier offers.

Specific penicillin G sodium historical data within the United States and Canada can also be provided.

Middle East and Africa Penicillin G Sodium Price Trend

Q2 2026:

The study includes penicillin G sodium price trends across the Middle East and Africa, taking into consideration variables that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical conflicts.

Q1 2026:

As per the penicillin G sodium price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.

Q4 2025:

The report explores the penicillin G sodium trends and penicillin G sodium price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on penicillin G sodium prices for countries can also be provided.

Asia Pacific Penicillin G Sodium Price Trend

Q2 2026:

The Asia Pacific penicillin G sodium market remained supported by established pharmaceutical manufacturing capacity and steady demand for antibiotic ingredients. China continued to influence regional supply conditions because penicillin G is produced through fermentation based processes that depend on precursor availability, microbial performance, utilities, and purification efficiency. Higher procurement interest from formulation manufacturers and export oriented suppliers supported firmer offers. Producers also remained attentive to manufacturing quality, batch consistency, and compliant processing, limiting aggressive discounting. Feedstock costs and plant operating expenses influenced producer margins, while logistics conditions affected delivered prices in importing markets.

Q1 2026:

In the Asia Pacific region, penicillin G sodium prices showed a steady increase. The region benefited from well established manufacturing infrastructure, which ensured continuous production and stable supply availability across major markets. Domestic demand from pharmaceutical manufacturers remained consistent, supported by ongoing healthcare requirements and steady antibiotic consumption. Export activity played a crucial role in maintaining equilibrium, as producers efficiently managed outbound shipments to prevent inventory accumulation in domestic markets.

Q4 2025:

In the Asia Pacific, the fourth quarter reflected balanced supply conditions and moderate export activity for penicillin G sodium. Major manufacturing hubs maintained stable fermentation output, supported by consistent raw material sourcing and steady operational performance. Domestic pharmaceutical production remained aligned with healthcare demand, while export volumes continued at a measured pace without creating supply constraints. Input costs, including utilities and labor, showed limited fluctuations, allowing producers to maintain steady operating margins.

Q3 2025:

Asia Pacific experienced upward pricing trends due to active export markets and firm domestic pharmaceutical production. Major manufacturing countries maintained steady fermentation output, but robust overseas inquiries strengthened producers’ bargaining positions. Export-oriented suppliers prioritized contract fulfillment, which occasionally limited spot market availability. Domestic demand from formulation manufacturers remained stable, supported by routine healthcare consumption and seasonal procurement cycles.

This penicillin G sodium price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Penicillin G Sodium Price Trend

Q2 2026:

Latin America's penicillin G sodium market is heavily influenced by its abundant natural resources, particularly in Chile and Brazil. However, political instability and inconsistencies in regulatory regimes can cause significant fluctuation in penicillin G sodium pricing.

Q1 2026:

Latin America's penicillin G sodium market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in penicillin G sodium prices.

Q3 2025:

Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, the penicillin G sodium price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing penicillin G sodium pricing trends in this region.

This comprehensive review can be extended to include specific countries within the region.

Penicillin G Sodium Pricing Report, Market Analysis, and News

IMARC's latest publication, “Penicillin G Sodium Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the penicillin G sodium market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of penicillin G sodium at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed penicillin G sodium prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting penicillin G sodium pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Penicillin G Sodium Industry Analysis

The global penicillin G sodium market size reached 71.4 Thousand Tons in 2025. By 2034, IMARC Group expects the market to reach 93.6 Thousand Tons, at a projected CAGR of 2.96% during 2026-2034. The market is primarily driven by the rising global antibiotic demand, expanding pharmaceutical manufacturing capacity, and steady healthcare infrastructure development.

Latest News and Developments:

• May 2025: A new pharmacokinetic study highlighted challenges in optimizing benzylpenicillin, also known as penicillin G, for long acting use in rheumatic heart disease and syphilis. Researchers found that at very low concentrations, the drug shows higher distribution and clearance. Among renal markers, cystatin C based eGFR better predicted drug clearance than creatinine measures. The findings supported precision dosing strategies and may guide development of improved long acting formulations to enhance adherence and therapeutic effectiveness worldwide.

Product Description

Benzylpenicillin sodium, also known as penicillin G sodium, is a water soluble beta lactam antibiotic belonging to the penicillin group. It is a biologically derived pharmaceutical compound produced through microbial fermentation using suitable Penicillium strains. During manufacturing, the fermented broth is processed to recover penicillin G, which is subsequently extracted, purified, and converted into its sodium salt form. The sodium salt has high water solubility, making penicillin G sodium suitable for preparation of injectable formulations administered by intravenous or intramuscular routes. Penicillin G sodium exhibits antibacterial activity against susceptible bacteria and is used in the treatment of serious bacterial infections, including susceptible cases of septicemia, pneumonia, meningitis, endocarditis, and other severe infections. It has also been used in the management of infections caused by organisms such as susceptible streptococci, pneumococci, Listeria, and certain Clostridium species. Its established clinical utility, rapid systemic availability when administered parenterally, and broad history of therapeutic use have made it an important antibiotic active pharmaceutical ingredient.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of penicillin G sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting penicillin G sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The penicillin G sodium price charts ensure our clients remain at the forefront of the industry.